황헌규 전문의,교수
#폐색전증#정맥혈전#만성폐질환#천식#페암#결핵#폐렴#금연클리닉#혈전클리닉
|
학력
순천향대학교 의과대학 졸업
경력
2011년 캐나다 Hamilton General hospital, McMaster University 유학
현)순천향대학교 부속 구미병원 호흡기알레르기내과 교수
현)순천향대학교 부속 구미병원 호흡기알레르기내과 교수
논문
1. Hwang HG, Schulman S. Respiratory Review of 2013: Pulmonary Thromboembolism. Tuberc Respir Dis 2013; 75(3): 89-94.
2. Hwang HG, Lee HS, Choi JS, Seo KH, Kim YH, Na JO. Risk Factors Influencing Rebleeding after Bronchial Artery Embolization on the Management of Hemoptysis Associated with Pulmonary Tuberculosis. Tuberc Respir Dis 2013; 74(3): 111-9.
3. Schulman S, Hwang HG et al. Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. Thrombosis research 2017; 152: 44-8.
4. Majeed A, Hwang HG, Eikelboom JW, et al. Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events. Thrombosis research 2016; 140: 81-8.
5. Bang SM, Hwang HG, Jang MJ, et al. Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines. J Korean Med Sci 2014; 29(2): 164-71.
6. Majeed A, Hwang HG, Connolly SJ, et al. Management and Outcomes of Major Bleeding during Treatment with Dabigatran or Warfarin. Circulation 2013.
2. Hwang HG, Lee HS, Choi JS, Seo KH, Kim YH, Na JO. Risk Factors Influencing Rebleeding after Bronchial Artery Embolization on the Management of Hemoptysis Associated with Pulmonary Tuberculosis. Tuberc Respir Dis 2013; 74(3): 111-9.
3. Schulman S, Hwang HG et al. Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. Thrombosis research 2017; 152: 44-8.
4. Majeed A, Hwang HG, Eikelboom JW, et al. Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events. Thrombosis research 2016; 140: 81-8.
5. Bang SM, Hwang HG, Jang MJ, et al. Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines. J Korean Med Sci 2014; 29(2): 164-71.
6. Majeed A, Hwang HG, Connolly SJ, et al. Management and Outcomes of Major Bleeding during Treatment with Dabigatran or Warfarin. Circulation 2013.
저서
저서 내용이 없습니다.
보도자료
순천향대 구미병원 '폐렴 적정성 평가' 4회 연속 최우수 1등급
https://sports.chosun.com/news/ntype.htm?id=202107160100124670007868&servicedate=20210715
투석 중인 AF 환자 '와파린→NOAC' 가능할까
http://www.monews.co.kr/news/articleView.html?idxno=202778
[종합] ‘나는 몸신이다’ “마른기침 8주이상 지속된다면 폐암 의심”…기침소리로 보는 폐건강 경고등
http://www.topstarnews.net/news/articleView.html?idxno=632844
결핵, "사라진 질병이 아니라 잊혀진 질병입니다"
https://www.breaknews.com/643282
https://sports.chosun.com/news/ntype.htm?id=202107160100124670007868&servicedate=20210715
투석 중인 AF 환자 '와파린→NOAC' 가능할까
http://www.monews.co.kr/news/articleView.html?idxno=202778
[종합] ‘나는 몸신이다’ “마른기침 8주이상 지속된다면 폐암 의심”…기침소리로 보는 폐건강 경고등
http://www.topstarnews.net/news/articleView.html?idxno=632844
결핵, "사라진 질병이 아니라 잊혀진 질병입니다"
https://www.breaknews.com/643282
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.